März W - Search Results

1

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations.

Rief M, Raggam R, Rief P, Metnitz P, Stojakovic T, Reinthaler M, Brodmann M, März W, Scharnagl H, Silbernagel G. Rief M, et al. Among authors: marz w. Biomedicines. 2022 Jul 21;10(7):1766. doi: 10.3390/biomedicines10071766. Biomedicines. 2022. PMID: 35885071 Free PMC article.

2

Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

Hoffmann MM, Scharnagl H, Panagiotou E, Banghard WT, Wieland H, März W. Hoffmann MM, et al. Among authors: marz w. J Am Soc Nephrol. 2001 Mar;12(3):524-530. doi: 10.1681/ASN.V123524. J Am Soc Nephrol. 2001. PMID: 11181800

3

Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol.

Scharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, März W. Scharnagl H, et al. Among authors: marz w. Am J Cardiol. 2004 Jan 15;93(2):219-20. doi: 10.1016/j.amjcard.2003.09.045. Am J Cardiol. 2004. PMID: 14715353 Clinical Trial.

4

Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.

Scharnagl H, Petersen G, Nauck M, Teichmann AT, Wieland H, März W. Scharnagl H, et al. Among authors: marz w. Contraception. 2004 Feb;69(2):105-13. doi: 10.1016/j.contraception.2003.10.004. Contraception. 2004. PMID: 14759614 Clinical Trial.

5

Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.

März W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR. März W, et al. Circulation. 2004 Nov 9;110(19):3068-74. doi: 10.1161/01.CIR.0000146898.06923.80. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505088

6

The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).

März W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR. März W, et al. Eur Heart J. 2004 Dec;25(23):2109-19. doi: 10.1016/j.ehj.2004.08.024. Eur Heart J. 2004. PMID: 15571826

7

Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

Renner W, Nauck M, Winkelmann BR, Hoffmann MM, Scharnagl H, Mayer V, Boehm BO, März W; LURIC Study team. Renner W, et al. Among authors: marz w. J Mol Med (Berl). 2005 Mar;83(3):235-9. doi: 10.1007/s00109-004-0618-0. Epub 2004 Dec 15. J Mol Med (Berl). 2005. PMID: 15599691

8

ApoE: crossroads between Alzheimer's disease and atherosclerosis.

Stojakovic T, Scharnagl H, März W. Stojakovic T, et al. Among authors: marz w. Semin Vasc Med. 2004 Aug;4(3):279-85. doi: 10.1055/s-2004-861496. Semin Vasc Med. 2004. PMID: 15630629 Review.

9

New lipid-lowering agents acting on LDL receptors.

Scharnagl H, März W. Scharnagl H, et al. Among authors: marz w. Curr Top Med Chem. 2005;5(3):233-42. doi: 10.2174/1568026053544524. Curr Top Med Chem. 2005. PMID: 15857307 Review.

10

Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.

Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, März W. Pilz S, et al. Among authors: marz w. J Clin Endocrinol Metab. 2006 Jul;91(7):2542-7. doi: 10.1210/jc.2006-0195. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

900 results

Search Page

Filters